IL103807A0 - Aminoalkylpyrrolidinylthio-carbapenem derivatives - Google Patents

Aminoalkylpyrrolidinylthio-carbapenem derivatives

Info

Publication number
IL103807A0
IL103807A0 IL103807A IL10380792A IL103807A0 IL 103807 A0 IL103807 A0 IL 103807A0 IL 103807 A IL103807 A IL 103807A IL 10380792 A IL10380792 A IL 10380792A IL 103807 A0 IL103807 A0 IL 103807A0
Authority
IL
Israel
Prior art keywords
group
hydrogen atom
lower alkyl
different
same
Prior art date
Application number
IL103807A
Other languages
English (en)
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of IL103807A0 publication Critical patent/IL103807A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • External Artificial Organs (AREA)
IL103807A 1991-11-27 1992-11-19 Aminoalkylpyrrolidinylthio-carbapenem derivatives IL103807A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33588891 1991-11-27
JP21561392 1992-07-21

Publications (1)

Publication Number Publication Date
IL103807A0 true IL103807A0 (en) 1993-04-04

Family

ID=26520964

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103807A IL103807A0 (en) 1991-11-27 1992-11-19 Aminoalkylpyrrolidinylthio-carbapenem derivatives

Country Status (18)

Country Link
US (1) US5550121A (fr)
EP (1) EP0545290B1 (fr)
KR (1) KR0175674B1 (fr)
CN (1) CN1032061C (fr)
AT (1) ATE195736T1 (fr)
AU (2) AU651505B2 (fr)
BG (1) BG97965A (fr)
CA (1) CA2083980C (fr)
CZ (1) CZ150193A3 (fr)
DE (1) DE69231375T2 (fr)
FI (1) FI933346A7 (fr)
HU (2) HUT64345A (fr)
IL (1) IL103807A0 (fr)
MX (1) MX9206838A (fr)
PL (1) PL300122A1 (fr)
TW (1) TW209220B (fr)
WO (1) WO1993011128A1 (fr)
YU (1) YU100792A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
JP3848693B2 (ja) * 1994-07-06 2006-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規カルバペネム誘導体
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
US8093378B2 (en) * 2006-04-28 2012-01-10 Kaneka Corporation Crystallization method for intermediates of carbapenem antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
CA2033390A1 (fr) * 1989-12-29 1991-06-30 Susumu Nakagawa Derives de 2-¬(2-cyclopropylpyrrolidin-4-yl)thio|carbapeneme
JPH05255332A (ja) * 1991-11-27 1993-10-05 Banyu Pharmaceut Co Ltd アルキルアミノアルキルピロリジニルチオカルバペネム誘導体

Also Published As

Publication number Publication date
CA2083980C (fr) 2003-04-29
AU2963292A (en) 1993-06-03
KR0175674B1 (ko) 1999-03-20
WO1993011128A1 (fr) 1993-06-10
PL300122A1 (en) 1994-04-18
MX9206838A (es) 1993-05-31
CZ150193A3 (en) 1994-03-16
AU667786B2 (en) 1996-04-04
KR930703322A (ko) 1993-11-29
BG97965A (bg) 1994-05-27
EP0545290A1 (fr) 1993-06-09
FI933346A0 (fi) 1993-07-26
EP0545290B1 (fr) 2000-08-23
CN1073176A (zh) 1993-06-16
TW209220B (fr) 1993-07-11
AU651505B2 (en) 1994-07-21
US5550121A (en) 1996-08-27
ATE195736T1 (de) 2000-09-15
DE69231375D1 (de) 2000-09-28
HU9302170D0 (en) 1993-10-28
CN1032061C (zh) 1996-06-19
HUT64345A (en) 1993-12-28
HU210817A9 (en) 1995-08-28
YU100792A (sh) 1995-10-24
AU7589494A (en) 1995-01-27
FI933346A7 (fi) 1993-07-26
CA2083980A1 (fr) 1993-05-28
DE69231375T2 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
HU9401221D0 (en) New heterocyclic compounds
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
ES8704485A1 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
UA35557C2 (uk) Похідні 1,2,4-оксадіазолілфеноксіалкілізоксазолу, що мають противірусну активність та фармацевтична композиція на їх основі
AU2013395A (en) 11,21-bisphenyl-19-norpregnane derivatives
MY132009A (en) Pharmaceutical compounds.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
HU210817A9 (en) Aminoalkylpyrrolidinylthiocarbapenem derivatives
AU631671B2 (en) 2-(2-vinylpyrrolidinylthio)carbapenem derivatives
ES8608495A1 (es) Procedimiento para la obtencion de nuevos compuestos de aralquiltriazol
BG97633A (en) Indenoindole compounds
HU911922D0 (en) New medical preparations containing 3,7-diazabicyclo(3.3.1)nonane compounds
NO932685L (no) Aminoalkyl-pyrrolidinyl-tiokarbapenem-derivater
AU576412B2 (en) Furazan derivatives
GR3017813T3 (en) 6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same.
IE45702L (en) Pyridobenzodiazepinones
RU93050006A (ru) Производные аминоалкилпирролидининилтиокарбапенема, способ их получения, промежуточное соединение, антибактериальный агент и способ лечения
AU2212692A (en) N,n',n'-trisubstituted-5-bis-aminomethylene-13-dioxane-4, 6-dione inhibitors of acyl-coa:cholesterol-acyl transferase
ES8504828A1 (es) Procedimiento para la obtencion de un derivado de organofosfato.
AU8291287A (en) Piperidine and azepine derivatives